Kirsty Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Insulin aspart, rDNA

Indications/Uses

DM in adults, adolescents & childn ≥1 yr.

Click to view Kirsty detailed prescribing information

Dosage/Direction for Use

SC/IV 0.5-1 U/kg daily in combination w/ intermediate- or long-acting insulin.

Click to view Kirsty detailed prescribing information

Overdosage

View Kirsty overdosage for action to be taken in the event of an overdose.

Administration

Should be taken with food: Administer immediately before or soon after a meal.

Contraindications

Hypersensitivity.

Click to view Kirsty detailed prescribing information

Special Precautions

Diabetic ketoacidosis; hypo- & hyperglycaemia; infections & feverish conditions; diseases affecting adrenal, pituitary or thyroid gland; lipodystrophy & cutaneous amyloidosis; inj site reactions. Physical activity, diet changes or during concomitant illness. Monitor blood glucose during infusion. Not to be mixed w/ other insulin prep. Combination w/ thiazolidinediones in heart failure patients. May affect ability to drive & use machines. Renal or hepatic impairment. Carefully control & monitor blood glucose during pregnancy & lactation. Childn <1 yr. Elderly ≥65 yr.

Click to view Kirsty detailed prescribing information

Use In Pregnancy & Lactation

Click to view Kirsty detailed prescribing information

Adverse Reactions

Hypoglycaemia.

Drug Interactions

Reduced insulin requirement w/ oral antidiabetics, MAOIs, β-blockers, ACE inhibitors, salicylates, anabolic steroids, sulfonamides. Increased insulin requirement w/ OCs, thiazides, glucocorticoids, thyroid & growth hormones, sympathomimetics, danazol. Masked hypoglycaemia symptoms by β-blockers. Increased or decreased insulin requirement w/ octreotide/lanreotide; alcohol.

Click to view Kirsty detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Kirsty detailed prescribing information

Storage

View Kirsty storage conditions for details to ensure optimal shelf-life.

Description

View Kirsty description for details of the chemical structure and excipients (inactive components).

Action

View Kirsty mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Insulin Preparations

ATC Classification

A10AB05 - insulin aspart ; Belongs to the class of fast-acting insulins and analogues. Used in the treatment of diabetes.

Regulatory Classification

Patient Counseling Information

View Kirsty patient counselling information

Presentation/Packing

Form

Kirsty soln for inj (pre-filled pen) 100 U/mL

Packing/Price

3 mL x 1's;3 mL x 3 × 1's;3 mL x 5 × 1's

Kirsty

insulin aspart

Manufacturer:

Biocon

Distributor:

Duopharma Marketing